Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BARDA To Fund Pediatric Development Of Cempra’s Solithromycin

This article was originally published in The Pink Sheet Daily

Executive Summary

Antibiotic-focused biotech can earn $58 million over five years under the government contract, which provides for testing of the novel macrolide in pediatric indications and for protection against bioterror-threat pathogens.

Advertisement

Related Content

Solithromycin Proves Safe, Makes Cempra A Deal Target
Antibiotic Development Incentives Face Critical Test As NDA Reviews Begin
Antibiotic Development Incentives Face Critical Test As NDA Reviews Begin
Antibiotic Development: As FDA’s QIDP List Grows Longer, Will Firms GAIN Less?
Deals Of The Week Ponders When $2.1 Billion Is A Steal
Deals Of The Week: Novartis/Penn, MEI Pharma/SBIO, Cempra/Curetis
Deals Of The Week: GlaxoSmithKline/BARDA, Evotec/Roche, F-Star/Merck Serono
Cempra Pharmaceuticals Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS075763

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel